Cronin, O., Blanch-Rubió, J., & Ralston, S. H. (2019). Zoledronate in the prevention of Paget’s (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone.
Citación estilo ChicagoCronin, Owen, Josep Blanch-Rubió, y Stuart H. Ralston. Zoledronate in the Prevention of Paget’s (ZiPP): Protocol for a Randomised Trial of Genetic Testing and Targeted Zoledronic Acid Therapy to Prevent SQSTM1-mediated Paget’s Disease of Bone. 2019.
Cita MLACronin, Owen, Josep Blanch-Rubió, y Stuart H. Ralston. Zoledronate in the Prevention of Paget’s (ZiPP): Protocol for a Randomised Trial of Genetic Testing and Targeted Zoledronic Acid Therapy to Prevent SQSTM1-mediated Paget’s Disease of Bone. 2019.